Gili Kenet

Recombinant Activated Factor VII for Adjunctive Hemorrhage Control in Trauma

U. Martinowitz, Gili Kenet, Eran Segal et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2001 · 448 citations

Factor VIII Products and Inhibitor Development in Severe Hemophilia A

Samantha C. Gouw, Johanna G. van der Bom, Rolf Ljung et al. · New England Journal of Medicine · 2013 · 431 citations · Full text

Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in Children

Gili Kenet, Siegal Sadetzki, Havi Murad et al. · Stroke · 2000 · 299 citations · Full text

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

Christoph Male, Anthonie W.A. Lensing, Joseph S. Palumbo et al. · The Lancet Haematology · 2019 · 294 citations · Full text

Pulmonary Embolism, Thrombosis, Venous Thrombosis +9

Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study

Gili Kenet, Fenella J. Kirkham, Thomas Niederstadt et al. · The Lancet Neurology · 2007 · 216 citations · Full text